InsidersTradesSigma
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by ENLOE J DAVID JR, Chairman & CEO. Director active across 2 companies, notably Recro Pharma, Inc.. In total, 15 disclosures have been logged. Total volume traded: €14k. The latest transaction was filed on 15 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
€1,0161,562 shares@ €0.65030.0000% mcap2.8% of flow
Common Stock
SEC:0001062993-22-015149:0·
Ideal exit: 12 Mar 2023 (T+270)
€1,0001,086 shares@ €0.92060.0000% mcap2.8% of flow
Common Stock
SEC:0001062993-22-012918:0·
Ideal exit: 10 Feb 2023 (T+270)
€945625 shares@ €1.51180.0000% mcap2.6% of flow
Common Stock
SEC:0001062993-22-010465:0·
Ideal exit: 13 Jan 2023 (T+270)
€32,85922,590 shares@ €1.45460.0000% mcap91.7% of flow
Common Stock
SEC:0001062993-22-009516:0·
€917512 shares@ €1.79118.1% of flow
Common Stock
SEC:0001062993-22-008073:0·
Ideal exit: 10 Dec 2022 (T+270)
€894571 shares@ €1.565517.2% of flow
Common Stock
SEC:0001062993-22-004789·
Ideal exit: 12 Nov 2022 (T+270)
€894571 shares@ €1.56557.9% of flow
Common Stock
SEC:0001062993-22-004789:0·
Ideal exit: 12 Nov 2022 (T+270)
66,007 shares
Common Stock
SEC:0000899243-22-003083:0·
66,007 shares
Common Stock
SEC:0000899243-22-003083·
€886602 shares@ €1.472317.1% of flow
Common Stock
SEC:0000899243-22-002423·
Ideal exit: 15 Oct 2022 (T+270)
€886602 shares@ €1.47237.8% of flow
Common Stock
SEC:0000899243-22-002423:0·
Ideal exit: 15 Oct 2022 (T+270)
€882617 shares@ €1.429717.0% of flow
Common Stock
SEC:0000899243-21-048870·
Ideal exit: 11 Sept 2022 (T+270)
€882617 shares@ €1.42977.8% of flow
Common Stock
SEC:0000899243-21-048870:0·
Ideal exit: 11 Sept 2022 (T+270)
€2,5281,725 shares@ €1.465748.7% of flow
Common Stock
SEC:0000899243-21-044709·
Ideal exit: 9 Aug 2022 (T+270)
€2,5281,725 shares@ €1.465722.4% of flow
Common Stock
SEC:0000899243-21-044709:0·
Ideal exit: 9 Aug 2022 (T+270)
15 of 15 declarations
About ENLOE J DAVID JR
David J Enloe Jr is an executive at Recro Pharma, Inc.
